Physician profile
David Auguste
NPI 1851680565
$22,273.28
in general payments reported to CMS, 2019-2025
40 companies · $4,081 in 2025
The $4,081 reported for 2025 was more than what 92% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,096 · 2020: $441 · 2021: $2,431 · 2022: $2,188 · 2023: $2,450 · 2024: $3,587 · 2025: $4,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,406 · Long Term Medical Supply Or Device Loan: $3,514 · Travel and Lodging: $2,197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,406.34 |
| Long Term Medical Supply Or Device Loan | $3,514.16 |
| Travel and Lodging | $2,197.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,145.80 | 2019-2025 | Ortholoc 2 Lapifuse, Inbone, Ortholoc 3di |
| Integra Lifesciences Corporation | $4,587.99 | 2019-2025 | Amnioexcel Plus, Integra, Integra Dermal Regeneration Template |
| Arthrex, INC. | $4,554.71 | 2019-2021 | |
| Wright Medical Technology, INC. | $1,083.96 | 2019-2020 | |
| Smith+Nephew, INC. | $815.80 | 2019-2025 | Grafix Pl, Bone Anchors With Arthroscopic Delivery System, Collagenase Santyl |
| Mvp Orthopedics INC | $766.80 | 2019-2022 | |
| Biocomposites INC | $301.76 | 2019-2020 | |
| Kci USA, INC. | $259.53 | 2019-2023 | 3m Cavilon, Activ.A.C. |
| Novo Nordisk INC | $238.49 | 2023-2024 | Wegovy |
| Organogenesis INC. | $212.28 | 2021-2023 | Puraply |
| Orthofix Medical, INC. | $202.80 | 2021-2024 | Physio-Stim |
| Polynovo North America LLC | $187.98 | 2024-2025 | Novosorb Btm |
| Horizon Therapeutics Plc | $178.20 | 2021-2023 | Krystexxa |
| Nevro Corp. | $154.93 | 2023 | Senza |
| In2bones USA, LLC | $148.50 | 2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $138.65 | 2019 | |
| Avanos Medical | $130.67 | 2019 | |
| Medtronic Vascular, INC. | $124.48 | 2020 | |
| Novastep INC. | $122.56 | 2022 | |
| Amgen INC. | $121.84 | 2024 | |
| Paratek Pharmaceuticals, INC. | $101.57 | 2021-2025 | Nuzyra |
| Pfizer INC. | $94.24 | 2023 | |
| Coastal Medical Technologies LLC | $78.75 | 2024-2025 | |
| Globus Medical, INC. | $69.68 | 2019 | |
| Depuy Synthes Sales INC. | $45.59 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $42.37 | 2023 | Dermaspan Tissue Expander |
| Treace Medical Concepts, INC. | $41.46 | 2024-2025 | |
| Reprise Biomedical, INC. | $34.51 | 2024 | Miro3d |
| Bioventus LLC | $33.43 | 2020-2022 | |
| Next Science LLC | $33.30 | 2023 | Xperience, Blastx, Surgx |
| Linvatec Corporation | $29.94 | 2022 | |
| Axogen | $28.53 | 2021 | |
| Kerecis Limited | $24.97 | 2021 | |
| Acell, INC. | $24.29 | 2020 | |
| Medtronic, INC. | $24.16 | 2023 | Intellis Adaptivestim |
| Trice Medical, INC. | $24.05 | 2025 | |
| Lifenet Health | $23.03 | 2023 | |
| Polarityte, INC. | $18.53 | 2019 | |
| Nabriva Therapeutics, Plc | $12.57 | 2020 | |
| Arteriocyte Medical Systems, INC. | $10.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Auguste listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.